Logo

Publications

Science Articles
Science Reviews
Patents & Patents Appl.
  • BioSpace.com – 7/14/2015. Avineuro Completed Phase II Clinical Study Of AVN-211, A Selective 5-HT6 Receptor Antagonist
  • About us
  • Pipeline
  • Our Team
    • Board of Directors
    • Scientific Advisory Board
  • Partners
  • Publications
    • Science Articles
    • Science Reviews
    • Patents & Patents Appl.
  • News and events
  • Contact us

(c) 2010. Avineuro Pharmaceuticals.
All Rights reserved.